Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases.

Nature immunology·2026
Same author

A multi-ethnic reference map of T cell receptor germline diversity reveals evidence of natural selection on alpha chain genes.

Nature communications·2026
Same author

HLA-DR risk variants in rheumatoid arthritis: what we know and still do not know.

RMD open·2026
Same author

Early and late RNA eQTL are driven by different genetic mechanisms.

Nature communications·2026
Same author

A population-scale atlas of blood and tissue in lupus nephritis.

bioRxiv : the preprint server for biology·2026
Same author

[Rheumatoid arthritis : synovial biopsies to select the best treatment ?]

Revue medicale suisse·2026

Related Experiment Video

Updated: Jun 23, 2026

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

9.3K

Understanding rheumatic disease through continuous cell state analysis.

Lysette Marshall1, Soumya Raychaudhuri1,2,3,4, Sebastien Viatte5,6,7

  • 1Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.

Nature Reviews. Rheumatology
|May 7, 2025
PubMed
Summary

New insights into autoimmune rheumatic diseases reveal novel cell types and states. Understanding cellular taxonomy is crucial for developing targeted therapies and biomarkers for conditions like rheumatoid arthritis and lupus.

More Related Videos

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

19.3K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

4.1K

Related Experiment Videos

Last Updated: Jun 23, 2026

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

9.3K
Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

19.3K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

4.1K

Area of Science:

  • Immunology
  • Rheumatology
  • Computational Biology

Background:

  • Autoimmune rheumatic diseases (e.g., rheumatoid arthritis, lupus) are complex and heterogeneous.
  • Single-cell technologies reveal novel immune cell populations (e.g., TPH cells, MerTK+ myeloid cells) implicated in disease.
  • Defining distinct cell types and lineages is challenging with emerging high-resolution assays.

Purpose of the Study:

  • To review current understanding of cell types and states in autoimmune rheumatic disease pathogenesis.
  • To explore evolving perspectives on immune and stromal cell taxonomy.
  • To discuss the implications of cell identity frameworks for therapeutic strategies and biomarker discovery.

Main Methods:

  • Review of recent literature on single-cell omics in autoimmune rheumatic diseases.
  • Analysis of shifting definitions and computational approaches for cell type identification.
  • Discussion of clinical implications for treatment and stratified medicine.

Main Results:

  • Identification of specific cell types like T peripheral helper (TPH) cells and MerTK+ myeloid cells in RA and lupus.
  • Highlighting the controversy and evolving nature of cell type definitions in high-resolution omics.
  • Emphasizing the link between computational methods, cell identity interpretation, and disease understanding.

Conclusions:

  • Accurate cell taxonomy is essential for understanding autoimmune rheumatic disease pathogenesis.
  • Ambiguity in cell identity hinders translation of research findings to clinical applications.
  • Clearer cell identity frameworks are needed for effective disease treatment and biomarker development in stratified medicine.